前收市價 | 41.40 |
開市 | 41.40 |
買盤 | 39.25 |
賣出價 | 41.35 |
拍板 | 300.00 |
到期日 | 2026-01-16 |
今日波幅 | 41.40 - 41.40 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 155 |
The latest trading day saw Amgen (AMGN) settling at $298.50, representing a -0.86% change from its previous close.
There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.
Viridian (VRDN) intends to initiate two late-stage studies on its experimental thyroid eye disease drug this August. Top-line data from both studies are expected in first-half 2026